“food-and-drug-administration” Archives

in
Entry Author Date Location
Bio Roundup: Gottlieb Exits, Bristol Defends, Biogen Buys & More 03/08/19 National
Two Years and Done: FDA Commissioner Gottlieb To Resign 03/05/19 National
Tasso Gets $6M For Device That Lets Users Self-Collect Blood Samples 03/05/19 Seattle
Blaze Bio Raises $5M to Help Surgeons See Tumors From Healthy Tissue 02/20/19 Seattle
Magnolia Medical Captures $20M to Reduce Blood Culture Contamination 02/01/19 Seattle
Sentinel Healthcare Raises $2M For Hypertension-Monitoring Software 01/31/19 Seattle
Tech Companies Share Shutdown Losses, With Little Chance of Back Pay 01/11/19 San Francisco
After Deal Stalled, Shine Medical Eyeing Up to $160M from Deerfield 11/26/18 Wisconsin
FDA Approves Elanco Cattle Drug, the First for Reducing Gas Emissions 11/07/18 Indiana
Stratatech Gets $26M More to Develop Skin Tissue for Treating Burns 10/16/18 Wisconsin
InCube, VelocityTX Join Work to Develop Pediatric Medical Devices 10/08/18 Texas
Somna Rebrands Acid Reflux Band in Bid to Reach More Patients 09/26/18 Wisconsin
Packers, Cool Products, Cellectar & More: This Week’s WI Watchlist 09/20/18 Wisconsin
San Antonio’s Spinal Stabilization Technologies Snags $11M Funding 08/27/18 Texas
Bio Roundup: EpiPen Shortage, Bluebird’s Bet, Biotech IPOs & More 08/24/18 National
FDA Approves Kala Pharmaceuticals Drug for Post-Surgery Eye Pain 08/23/18 Boston
Bio Roundup: Alnylam’s Moment, Read on Rebates, Skinny Plans & More 08/03/18 National
HealthMyne, Developer of Health Records Analytics Software, Adds $15M 08/02/18 Wisconsin
FDA Approves NorthStar Medical to Make Isotope Generator at WI Plant 07/24/18 Wisconsin
Agios Pharma’s Drug for Rare Blood Cancer Wins Speedy FDA Nod 07/20/18 Boston
PTC Dives Into Gene Therapy with $50M Agilis Biotherapeutics Deal 07/19/18 New York
With New Data, Amgen Tries Again for FDA OK of Osteoporosis Drug 07/13/18 San Francisco
Bio Roundup: Pfizer’s Prices, Novartis Cuts, Gene Therapy Guide & More 07/13/18 National
Gregor Diagnostics Raises $900K to Develop New Prostate Cancer Test 07/10/18 Wisconsin
Acceleron, Celgene Drug Shines in Phase 3 Test in Rare Blood Disorder 07/09/18 Boston
CTI BioPharma’s Non-Hodgkin Lymphoma Drug Fails Study, Shares Sink 07/09/18 Seattle
Boston Scientific Continues M&A Streak with $202M Deal for Cryterion 07/05/18 Boston
Priority Changes for Novartis Spell the End for Aveo Pharma Alliance 07/03/18 Boston
Fresh Off Launch of First Test, TAI Diagnostics Adds Funding 07/02/18 Wisconsin
Nanotech Liquidia Hops IPO Wave as Lead Drug Faces Late-Stage Test 06/29/18 Raleigh Durham
Page 1 of 12 next page »